Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.

[1]  Haitao Fan,et al.  M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3 , 2020, Cancer Cell International.

[2]  Yigang Chen,et al.  CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Guojun Wu,et al.  A stroma-corrected ZEB1 transcriptional signature is inversely associated with antitumor immune activity in breast cancer , 2019, Scientific Reports.

[4]  Xin Meng,et al.  Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1. , 2019, Acta biochimica et biophysica Sinica.

[5]  J. Olsen,et al.  Upregulation of PD‐1 follows tumour development in the AOM/DSS model of inflammation‐induced colorectal cancer in mice , 2019, Immunology.

[6]  Jae Cheol Lee,et al.  Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer , 2019, Experimental & Molecular Medicine.

[7]  T. Tan,et al.  The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells , 2019, Communications Biology.

[8]  Z-P Tan.  Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[9]  R. Blelloch,et al.  Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory , 2019, Cell.

[10]  M. Haris,et al.  Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance , 2019, Molecular Cancer.

[11]  Min Fu,et al.  Exosomes in gastric cancer: roles, mechanisms, and applications , 2019, Molecular Cancer.

[12]  Xiuzhen Han,et al.  The roles of ZEB1 in tumorigenic progression and epigenetic modifications. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Xiaokun Shen,et al.  Immunotherapy for gastric cancer: dilemmas and prospect , 2018, Briefings in functional genomics.

[14]  Huan Liu,et al.  Clinical significance of exosomal miRNAs and proteins in three human cancers with high mortality in China , 2018, Oncology letters.

[15]  A. Fattorossi,et al.  Extracellular Vesicles in Oncology: Progress and Pitfalls in the Methods of Isolation and Analysis , 2018, Biotechnology journal.

[16]  T. Kanda,et al.  EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions , 2018, Gastric Cancer.

[17]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[18]  Jing Liu,et al.  Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins. , 2018, Cancer letters.

[19]  Zhengrong Chen,et al.  Melanoma‐released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo , 2018, Experimental cell research.

[20]  Junshan Ruan,et al.  Extracellular Vesicles: A New Perspective in Tumor Therapy , 2018, BioMed research international.

[21]  C. Emiliani,et al.  Extracellular Vesicles as Conveyors of Membrane-Derived Bioactive Lipids in Immune System , 2018, International journal of molecular sciences.

[22]  Sachin Mulmi Shrestha,et al.  The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer , 2018, BioMed research international.

[23]  J. Ajani,et al.  Medical management of gastric cancer: a 2017 update , 2017, Cancer medicine.

[24]  H. Yao,et al.  HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity , 2018, Nature Chemical Biology.

[25]  A. Masamune,et al.  Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells. , 2018, Biochemical and biophysical research communications.

[26]  Y. Fujiwara,et al.  Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression. , 2018, Anticancer research.

[27]  Wei-Jun Yang,et al.  MicroRNA expression profiling in exosomes derived from gastric cancer stem-like cells , 2017, Oncotarget.

[28]  E. Oki,et al.  Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma , 2017, Cancer science.

[29]  B. Shen,et al.  Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner , 2017, International journal of nanomedicine.

[30]  Qi Zhou,et al.  Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy , 2017, Cellular Physiology and Biochemistry.

[31]  X. Fu,et al.  Grhl2 reduces invasion and migration through inhibition of TGFβ-induced EMT in gastric cancer , 2017, Oncogenesis.

[32]  E. Fuentes-Pananá,et al.  Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. , 2017, Current topics in microbiology and immunology.

[33]  H. Abrahamse,et al.  The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. , 2016, Journal of photochemistry and photobiology. B, Biology.

[34]  Qiang Chen,et al.  sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells. , 2016, Gene.

[35]  R. Luo,et al.  Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells. , 2016, Oncology letters.

[36]  Dajun Yang,et al.  Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. , 2015, International journal of clinical and experimental pathology.

[37]  E. Krzywińska,et al.  Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer , 2015, Experimental biology and medicine.

[38]  Lixia Diao,et al.  Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression , 2014, Nature Communications.

[39]  H. Ford,et al.  Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. , 2013, Cancer research.

[40]  Xiang Fu,et al.  Expression and role of grainyhead-like 2 in gastric cancer , 2013, Medical Oncology.

[41]  O. Kallioniemi,et al.  FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. , 2010, Cancer research.